These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

664 related items for PubMed ID: 29581249

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) protects against renal ischemia/reperfusion injury by inhibiting inflammation.
    Miao AF, Liang JX, Yao L, Han JL, Zhou LJ.
    Ren Fail; 2021 Dec; 43(1):803-810. PubMed ID: 33966598
    [Abstract] [Full Text] [Related]

  • 3. Hypoxia-inducible factor prolyl-hydroxylase inhibitor roxadustat (FG-4592) alleviates sepsis-induced acute lung injury.
    Han F, Wu G, Han S, Li Z, Jia Y, Bai L, Li X, Wang K, Yang F, Zhang J, Wang X, Guan H, Linlin S, Han J, Hu D.
    Respir Physiol Neurobiol; 2020 Oct; 281():103506. PubMed ID: 32726645
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China.
    Chen N, Qian J, Chen J, Yu X, Mei C, Hao C, Jiang G, Lin H, Zhang X, Zuo L, He Q, Fu P, Li X, Ni D, Hemmerich S, Liu C, Szczech L, Besarab A, Neff TB, Peony Yu KH, Valone FH.
    Nephrol Dial Transplant; 2017 Aug 01; 32(8):1373-1386. PubMed ID: 28371815
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ursodeoxycholic acid protects against cisplatin-induced acute kidney injury and mitochondrial dysfunction through acting on ALDH1L2.
    Yang Y, Liu S, Gao H, Wang P, Zhang Y, Zhang A, Jia Z, Huang S.
    Free Radic Biol Med; 2020 May 20; 152():821-837. PubMed ID: 32004633
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the Carcinogenic Potential of Roxadustat (FG-4592), a Small Molecule Inhibitor of Hypoxia-Inducible Factor Prolyl Hydroxylase in CD-1 Mice and Sprague Dawley Rats.
    Beck J, Henschel C, Chou J, Lin A, Del Balzo U.
    Int J Toxicol; 2017 May 20; 36(6):427-439. PubMed ID: 29153032
    [Abstract] [Full Text] [Related]

  • 11. Roxadustat attenuates experimental pulmonary fibrosis in vitro and in vivo.
    Huang H, Wang X, Zhang X, Wang H, Jiang W.
    Toxicol Lett; 2020 Oct 01; 331():112-121. PubMed ID: 32534005
    [Abstract] [Full Text] [Related]

  • 12. FG-4592 Accelerates Cutaneous Wound Healing by Epidermal Stem Cell Activation via HIF-1α Stabilization.
    Tang D, Zhang J, Yan T, Wei J, Jiang X, Zhang D, Zhang Q, Jia J, Huang Y.
    Cell Physiol Biochem; 2018 Oct 01; 46(6):2460-2470. PubMed ID: 29742498
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. HIF activation protects from acute kidney injury.
    Weidemann A, Bernhardt WM, Klanke B, Daniel C, Buchholz B, Câmpean V, Amann K, Warnecke C, Wiesener MS, Eckardt KU, Willam C.
    J Am Soc Nephrol; 2008 Mar 01; 19(3):486-94. PubMed ID: 18256363
    [Abstract] [Full Text] [Related]

  • 15. Evidence for the Capability of Roxadustat (FG-4592), an Oral HIF Prolyl-Hydroxylase Inhibitor, to Perturb Membrane Ionic Currents: An Unidentified yet Important Action.
    Chang WT, Lo YC, Gao ZH, Wu SN.
    Int J Mol Sci; 2019 Nov 29; 20(23):. PubMed ID: 31795416
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Preischemic targeting of HIF prolyl hydroxylation inhibits fibrosis associated with acute kidney injury.
    Kapitsinou PP, Jaffe J, Michael M, Swan CE, Duffy KJ, Erickson-Miller CL, Haase VH.
    Am J Physiol Renal Physiol; 2012 May 01; 302(9):F1172-9. PubMed ID: 22262480
    [Abstract] [Full Text] [Related]

  • 19. Roxadustat (FG-4592) protects against ischaemia-induced acute kidney injury via improving CD73 and decreasing AIM2 inflammasome activation.
    Yang H, Wu Y, Cheng M, Zhang M, Qiu X, Liu S, Zhang M.
    Nephrol Dial Transplant; 2023 Mar 31; 38(4):858-875. PubMed ID: 36413468
    [Abstract] [Full Text] [Related]

  • 20. Stabilization of HIF-1α by FG-4592 promotes functional recovery and neural protection in experimental spinal cord injury.
    Wu K, Zhou K, Wang Y, Zhou Y, Tian N, Wu Y, Chen D, Zhang D, Wang X, Xu H, Zhang X.
    Brain Res; 2016 Feb 01; 1632():19-26. PubMed ID: 26707978
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.